` ORNBV (Orion Oyj) vs DAX Index Comparison - Alpha Spread

ORNBV
vs
DAX Index

Over the past 12 months, ORNBV has significantly outperformed DAX Index, delivering a return of 49% compared to the DAX Index's 22% growth.

Stocks Performance
ORNBV vs DAX Index

Loading

Performance Gap
ORNBV vs DAX Index

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
ORNBV vs DAX Index

Loading
ORNBV
DAX Index
Add Stock

Competitors Performance
Orion Oyj vs Peers

DAX Index
ORNBV
LLY
JNJ
NOVO B
ROG
Add Stock

Orion Oyj
Glance View

Market Cap
7.5B EUR
Industry
Pharmaceuticals

Orion Oyj, a stalwart in the pharmaceutical industry, has carved out a significant niche for itself since its inception in Finland. The company was founded in 1917, and over the years, it has evolved into a crucial player in the global medical landscape. As a fully integrated pharmaceutical entity, Orion’s operations encompass everything from research and development to manufacturing and distribution. Its primary areas of focus include the development of therapies for central nervous system disorders, oncology, and respiratory diseases, as well as a selection of veterinary medicines and active pharmaceutical ingredients (APIs). This comprehensive approach enables Orion to maintain control over the entire drug production pipeline, ensuring quality and innovation are at the forefront of its mission. Orion's business strategy revolves around a robust combination of proprietary innovations and strategic partnerships. The company invests heavily in R&D, dedicating a substantial portion of its revenue to discovering and developing new drugs. By doing so, it fortifies its product pipeline, ensuring a steady influx of new offerings that cater to unmet medical needs, fostering a competitive edge in the market. Additionally, Orion supplements its earnings through collaborations with other pharmaceutical giants, expanding its market reach and sharing resources to mitigate risks associated with the costly drug development process. Through this dual approach of in-house excellence and collaborative ventures, Orion Oyj effectively sustains its financial health, continually fueling its growth and ensuring it remains a formidable force in the international pharmaceutical arena.

ORNBV Intrinsic Value
HIDDEN
Show
Back to Top